ClinOne vs. AQ Platform

ClinOne is an all-inclusive platform designed to improve the connectivity and empowerment of participants, caregivers, and clinical trial sites by delivering critical tools that promote trial awareness, manage consent, and enhance participant engagement and retention, all underpinned by comprehensive data analytics and standardized interoperability. One of its standout features, Site Hub, serves as a centralized location for trial sites to find essential information, such as participant eligibility criteria, available resources, and a unified systems landing page that includes single sign-on capabilities and options for community engagement. The Connect module adds further depth to the platform with components like the Sponsor & Monitor Hub, initiatives to raise trial awareness, a network for healthcare providers, streamlined site selection, and data that emphasizes diversity, equity, and inclusion. In parallel, the Inform module is dedicated to simplifying consent management and education, utilizing eConsent with eSignature capabilities, while also providing insights through data, facilitating tele-visits, and creating opportunities for community collaboration. Furthermore, the Empower module significantly enriches the clinical trial experience by offering transportation management services, monitoring medication adherence, and establishing a dedicated portal specifically for caregivers and care partners, thereby ensuring that participants receive comprehensive support throughout their clinical trial experience. Ultimately, ClinOne is committed to transforming the landscape of clinical trials by leveraging technology to create a more engaging and supportive environment for all stakeholders involved.

The AQ Platform is a sophisticated software solution designed specifically for overseeing clinical research across various entities such as NHS trusts, clinical trial units, investigator sites, site networks, CROs, sponsors, and academic research organizations. It includes an array of modules that support trial management, electronic documentation for both trials and investigator sites, operations in pharmacies and laboratories, quality assurance, corrective and preventive actions (CAPA), along with the digital delegation of authority. This platform facilitates the seamless integration of regulated trial records and comprehensive audit trails, leading to improved efficiency in study operations. By harnessing Connected Intelligence, the software utilizes AI to pinpoint potential gaps and propose subsequent actions, with the stipulation that each recommendation must be validated by a designated user, thereby ensuring that customer data remains confidential and is not employed for AI model training. Hosted within the UK regions of Microsoft Azure, the AQ Platform is meticulously crafted to comply with ICH E6(R3) guidelines and meets the standards anticipated by the MHRA for Good Clinical Practice inspections. Furthermore, AQ Trials has received the NHS DSPT Standards Met (2026) designation and holds Cyber Essentials certification, underscoring its dedication to security and adherence to regulatory requirements. Created by physicians specializing in Phase 1 trials, the system offers the flexibility of individual module deployment, and it has been actively implemented in NHS operations since 2020, which highlights its effectiveness and reliability in practical clinical environments. The platform is continuously being enhanced based on user feedback, ensuring it adapts to the evolving demands of clinical research while maintaining high standards of performance and user satisfaction. As a result, it stands as a robust solution in the ever-changing landscape of clinical trial management.